Patents by Inventor SREESHA P. SRINIVASA

SREESHA P. SRINIVASA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins
    Patent number: 11060097
    Abstract: The present invention provides for a composition and a method for treating a subject afflicted with a cancer, wherein the composition comprises therapeutically effective amounts of: (a) an anti-Programmed Death-Ligand 1 (PD-L1) antibody and (b) a targeted/immunomodulatory fusion protein comprising at least one tumor targeting moiety and at least one immunomodulatory moiety that counteracts the immune tolerance of cancer cells.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: July 13, 2021
    Inventors: Nagaraj Govindappa, Sreesha P. Srinivasa, Usha Bughani, Reshmi Nair
  • TARGETED/IMMUNOMODULATORY FUSION PROTEINS IN COMBINATION WITH ADDITIONAL THERAPEUTIC AGENTS AND METHODS FOR MAKING SAME
    Publication number: 20190169621
    Abstract: The present invention provides for a composition and a method for treating a subject afflicted with a cancer, wherein the composition comprises therapeutically effective amounts of: (a) an anti-Programmed Death-Ligand 1 (PD-L1) antibody and (b) a targeted/immunomodulatory fusion protein comprising at least one tumor targeting moiety and at least one immunomodulatory moiety that counteracts the immune tolerance of cancer cells.
    Type: Application
    Filed: January 31, 2019
    Publication date: June 6, 2019
    Inventors: NAGARAJ GOVINDAPPA, SREESHA P. SRINIVASA, USHA BUGHANI, RESHMI NAIR